Brian W. Brannigan
- Oncology top 0.1%
- Pulmonary and Respiratory Medicine top 0.05%
- Molecular Biology top 0.5%
- Cancer Research top 0.2%
- Pathology and Forensic Medicine top 1%
- Co-authors
- Daniel A. HaberDaphne W. BellThomas J. LynchRoss A. OkimotoRaffaella SordellaPatricia L. HarrisJeff SettlemanSara M. Haserlat
- Topics
- Lung Cancer Treatments and Mutations (10 papers)Cancer Cells and Metastasis (8 papers)HER2/EGFR in Cancer Research (6 papers)
- Partner nations
- United StatesItalyCanada
In The Last Decade
Brian W. Brannigan
25 papers receiving 15.0k citations
Hit Papers
Peers
Comparison fields: 5 of 137
- Oncology 9.5k
- Pulmonary and Respiratory Medicine 9.1k
- Molecular Biology 6.0k
- Cancer Research 4.3k
- Pathology and Forensic Medicine 858
Countries citing papers authored by Brian W. Brannigan
This map shows the geographic impact of Brian W. Brannigan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Brian W. Brannigan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Brian W. Brannigan more than expected).
Fields of papers citing papers by Brian W. Brannigan
This network shows the impact of papers produced by Brian W. Brannigan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Brian W. Brannigan. The network helps show where Brian W. Brannigan may publish in the future.
Co-authorship network of co-authors of Brian W. Brannigan
This figure shows the co-authorship network connecting the top 25 collaborators of Brian W. Brannigan. A scholar is included among the top collaborators of Brian W. Brannigan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Brian W. Brannigan. Brian W. Brannigan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 15 | |
| 2 | Circulating Tumor Cell Clusters Are Oligoclonal Precursors of Breast Cancer Metastasisbreakdown → | 1786 |
| 3 | 1 | |
| 4 | 79 | |
| 5 | 2 | |
| 6 | 217 | |
| 7 | 42 | |
| 8 | 83 | |
| 9 | 12 | |
| 10 | Detection of Mutations in EGFR in Circulating Lung-Cancer Cellsbreakdown → | 1295 |
| 11 | 10 | |
| 12 | 64 | |
| 13 | 225 | |
| 14 | 133 | |
| 15 | Irreversible inhibitors of the EGF receptor may circumvent acquired resistance to gefitinibbreakdown → | 774 |
| 16 | 380 | |
| 17 | 104 | |
| 18 | Epidermal Growth Factor Receptor Mutations and Gene Amplification in Non–Small-Cell Lung Cancer: Molecular Analysis of the IDEAL/INTACT Gefitinib Trialsbreakdown → | 518 |
| 19 | Activating Mutations in the Epidermal Growth Factor Receptor Underlying Responsiveness of Non–Small-Cell Lung Cancer to Gefitinibbreakdown → | 8906 |
| 20 | 22 |
About Brian W. Brannigan
Brian W. Brannigan is a scholar working on Oncology, Cancer Research and Pulmonary and Respiratory Medicine, having authored 25 papers that have together received 15.4k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (10 papers), Cancer Cells and Metastasis (8 papers) and HER2/EGFR in Cancer Research (6 papers). The work is most often cited by research in Oncology (9.5k citations), Cancer Research (4.3k citations) and Pulmonary and Respiratory Medicine (9.1k citations). Brian W. Brannigan has collaborated with scholars based in United States, Italy and Canada. Frequent co-authors include Daniel A. Haber, Daphne W. Bell, Thomas J. Lynch, Ross A. Okimoto, Raffaella Sordella, Patricia L. Harris, Jeff Settleman, Sara M. Haserlat, Frank G. Haluska and Jeffrey G. Supko. Their work appears in journals such as Science, New England Journal of Medicine and Cell.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.